Bronchiectasis Occurs Independently of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Deficiency.

IF 2.3 4区 医学 Q2 RESPIRATORY SYSTEM
Joshua De Soyza, Paul Ellis, Michael Newnham, Lloyd Rickard, Alice M Turner
{"title":"Bronchiectasis Occurs Independently of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Deficiency.","authors":"Joshua De Soyza, Paul Ellis, Michael Newnham, Lloyd Rickard, Alice M Turner","doi":"10.15326/jcopdf.2024.0526","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Bronchiectasis occurs in patients with alpha-1 antitrypsin deficiency (AATD), but it is unknown whether an association exists independently of chronic obstructive pulmonary disease (COPD). We assessed whether bronchiectasis was associated with COPD in our cohort, and whether it has clinical significance for lung function decline, exacerbation rate, or symptoms.</p><p><strong>Study design and methods: </strong>PiZZ, PiSZ and PiMZ patients from the Birmingham AATD Research Database were studied. Demographics were recorded, along with the outcomes of symptoms, FEV1, TLCO, KCO, and annualised exacerbation rate. Lung function decline was calculated for those with ≥3 measurements. Multivariate regression analyses were conducted to assess for associations of bronchiectasis with each outcome. A further binomial logistic regression model assessed for predictors of bronchiectasis diagnosis, including COPD. Those with alternative bronchiectasis causes were excluded from statistical models.</p><p><strong>Results: </strong>1290 patients were eligible. PiZZ patients with bronchiectasis were older at presentation (54 vs 49 years, p<0.001), less likely to have smoked (65 vs 76.1%, p = 0.001), and had higher mMRC scores (mMRC 2 vs 0 OR 1.97, 95% CI 1.20 - 3.25, p = 0.008; mMRC 3 vs 0 OR 2.58 95% CI 1.59 - 4.19, p<0.001; mMRC 4 vs 0 OR 2.2 95% CI 1.23 - 3.92; p=0.008) than those without. The odds ratio of bronchiectasis diagnosis was not associated with COPD diagnosis in any phenotype. Bronchiectasis was associated with lower serum alpha-1 antitrypsin levels in PiZZ patients (p = 0.012). Bronchiectasis was not associated with a difference in FEV1 pp/year decline, KCO pp/year, TLCO pp/year decline, or exacerbation rate in multivariate analysis.</p><p><strong>Conclusion: </strong>Bronchiectasis exists in a significant minority of AATD patients independently of COPD, and is associated with more severe shortness of breath. Appropriate treatment of bronchiectasis in AATD is essential.</p>","PeriodicalId":51340,"journal":{"name":"Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15326/jcopdf.2024.0526","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Bronchiectasis occurs in patients with alpha-1 antitrypsin deficiency (AATD), but it is unknown whether an association exists independently of chronic obstructive pulmonary disease (COPD). We assessed whether bronchiectasis was associated with COPD in our cohort, and whether it has clinical significance for lung function decline, exacerbation rate, or symptoms.

Study design and methods: PiZZ, PiSZ and PiMZ patients from the Birmingham AATD Research Database were studied. Demographics were recorded, along with the outcomes of symptoms, FEV1, TLCO, KCO, and annualised exacerbation rate. Lung function decline was calculated for those with ≥3 measurements. Multivariate regression analyses were conducted to assess for associations of bronchiectasis with each outcome. A further binomial logistic regression model assessed for predictors of bronchiectasis diagnosis, including COPD. Those with alternative bronchiectasis causes were excluded from statistical models.

Results: 1290 patients were eligible. PiZZ patients with bronchiectasis were older at presentation (54 vs 49 years, p<0.001), less likely to have smoked (65 vs 76.1%, p = 0.001), and had higher mMRC scores (mMRC 2 vs 0 OR 1.97, 95% CI 1.20 - 3.25, p = 0.008; mMRC 3 vs 0 OR 2.58 95% CI 1.59 - 4.19, p<0.001; mMRC 4 vs 0 OR 2.2 95% CI 1.23 - 3.92; p=0.008) than those without. The odds ratio of bronchiectasis diagnosis was not associated with COPD diagnosis in any phenotype. Bronchiectasis was associated with lower serum alpha-1 antitrypsin levels in PiZZ patients (p = 0.012). Bronchiectasis was not associated with a difference in FEV1 pp/year decline, KCO pp/year, TLCO pp/year decline, or exacerbation rate in multivariate analysis.

Conclusion: Bronchiectasis exists in a significant minority of AATD patients independently of COPD, and is associated with more severe shortness of breath. Appropriate treatment of bronchiectasis in AATD is essential.

α-1抗胰蛋白酶缺乏症患者的支气管扩张与慢性阻塞性肺病无关
简介:支气管扩张发生在α-1抗胰蛋白酶缺乏症(AATD)患者中,但是否与慢性阻塞性肺病(COPD)存在独立关联尚不清楚。我们评估了队列中支气管扩张是否与慢性阻塞性肺病相关,以及支气管扩张对肺功能下降、病情恶化率或症状是否有临床意义:研究对象为伯明翰 AATD 研究数据库中的 PiZZ、PiSZ 和 PiMZ 患者。研究人员记录了患者的人口统计学特征以及症状、FEV1、TLCO、KCO 和年化恶化率等结果。对测量值≥3的患者计算肺功能下降率。进行多变量回归分析以评估支气管扩张与各项结果的关联性。另一个二项式逻辑回归模型评估了支气管扩张症诊断的预测因素,包括慢性阻塞性肺病。统计模型排除了有其他支气管扩张病因的患者:共有 1290 名患者符合条件。PiZZ支气管扩张症患者在发病时年龄较大(54 岁对 49 岁,p 结论:支气管扩张症存在于不同年龄段的人群中:相当一部分 AATD 患者的支气管扩张与慢性阻塞性肺病无关,并且与更严重的气短有关。适当治疗 AATD 支气管扩张症至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
8.30%
发文量
45
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信